GMO U.S. Intrinsic Value III
40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | Large Value | | Fund Family: | GMO | | Net Assets: | 25.48M | | Year-to-Date Return: | -13.00% | | Yield: | 2.13% | | Morningstar Rating: |  | | Fund Inception Date: | 02-Aug-99 |
|
Sam Wilderman
Lead Manager since
30-Apr-05 | | | Wilderman is the director of U.S. equity management since 2005 and is responsible for all U.S. quantitative equities portfolio management at Grantham, Mayo, Van Otterloo & Co. LLC (GMO). Prior to this, he was a member of GMOs Emerging Markets Equity Group for nine years, focusing on research and portfolio management. Wilderman joined GMO in 1996. Wilderman holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $10,000,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks long-term capital growth. The fund typically makes equity investments in U.S. companies that issue stocks included in the Russell 1000 index. Under normal circumstances, the fund invests at least 80% of assets in investments tied to the U.S. |
| Last Dividend
(10-Jul-08):
| 0.04 | | Last Cap Gain
(21-Dec-07):
| 0.46 | | Annual Holdings Turnover
| 75.00% | | Average for Category:
| 59.99% |
|
| Expense | GMVUX | Category
Avg | | Total Expense Ratio: | 0.46%
| 1.27% | | Max 12b1 Fee: | 0.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.39% | | Max Deferred Sales Load: | 0.00%
| 2.67% | | 3 Yr Expense Projection*: |
$202 | $588 | | 5 Yr Expense Projection*: |
$370 | $902 | | 10 Yr Expense Projection*: |
$859 | $1,772 |
|
|
1.49% Nasdaq 
0.27%
Profile
